Recall: D-0725-2026

Class II - Potentially Harmful

Class IIClassification

2026-07-16Initiated

OngoingStatus

Fresenius Kabi USA, LLCFirm

Product

Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07

Reason

Presence of Particulate Matter: Hair was found in product

Distribution

Nationwide within in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.